Unveiling the PDK4-centered Rituximab-Resistant Mechanism in DLBCL: the Potential of the "smart" Exosome Nanoparticle Therapy.
MOLECULAR CANCER（2024）
关键词
Diffuse large B-cell lymphoma,PDK4,Rituximab resistance,Advanced exosome nanoparticles,Targeted therapy,Immunotherapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要